EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio S4 E19: HDV: The devil becomes treatable

EASL Studio Podcast S4 E19: HDV: The devil becomes treatable

EASL Studio S4 E18: Liver nurses in Europe: Are there enough and can they do more?

EASL Studio Podcast S4 E18: Liver nurses in Europe: Are there enough and can they do more?

EASL Studio S4 E17: Albumin in cirrhosis: For all, for some, for none

EASL Studio Podcast S4 E17: Albumin in cirrhosis: For all, for some, for none

EASL Studio S4 E16: Highlights from the EASL Liver Cancer Summit 2023

EASL Studio Podcast S4 E16: Highlights from the EASL Liver Cancer Summit 2023

EASL Studio S4 E15: Diagnostic and therapeutic challenges in Wilson’s disease

EASL Studio Podcast S4 E15: Diagnostic and therapeutic challenges in Wilson’s disease

EASL Policy Dialogues S2 E2: World Liver Day

EASL Studio S4 Special Edition: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance

EASL Studio Podcast S4 Special Edition: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance